Resident Corner

Starting Residency? What dermatology thought leaders want you to know
Starting Residency
by Brianna Olamiju on
Starting Residency?  During the 2018 Skin of Color Seminar Series(now the Skin of Color Update), Next Steps correspondent, Brianna Olamiju, spoke with some of the top dermatology thought leaders about what you should know. What are three pieces of advice you would give to an individual entering dermatology residency? Dr. Ted Rosen: Work towards developingan area of significant expertis …
It’s Pop Quiz Friday 7/27! Can you get it right?
by Next Steps In Derm Team on
A patient presents with nail findings seen here. Biopsy demonstrates fungus. The patient recently saw an add for a medication, Jublia (Efinaconazole). What is the medication of action? A.  Antifungal via inhibiting fungal lanosterol 14-alpha-demethylase B.  Inhibits squalene epoxidase C.  Inhibits DNA gyrase D.  Inhibits epithelial sodium channels E.  Binds ergosterol and forms por …
Ask a Mentor: On finding a niche in the field, developing a career in academics and better serving patients of color
As a mentor Dr. Amy McMichael
We are excited to announce another installment of our new recurring series: Ask a Mentor. In this monthly segment, we will identify an accomplished mentor in the field of Dermatology to answer your questions about career development and their unique areas of expertise. If you have questions on finding a niche in the field, developing a career in academics and/or better serving patients of color …
It’s Pop Quiz Friday 7/20! Let’s see if you get it right!
NS Cutaneous Leishmaniasis
Which of the following is true about this condition? A. Histology will show amastagotes in plasma cells. B. Cuture is performed on MacConkey agar. C. Diagnosis may be made by sending a sample for real-time PCR assay to the Centers for Disease Control and Prevention. D. This condition does not typically resolve without treatment. E. Treatment for cutaneous and …
It’s Pop Quiz Friday 7/6! Let’s see if you get it right!
NS Pop Quiz Friday 14
by Next Steps In Derm Team on
This patient is not a candidate for systemic therapy and declines surgical treatment. Which of the following injectable agents is an oncolytic virus that is FDA-approved for inoperable disease? A) Talimogene laherparepvec (T-VEC) B) Interleukin-2 C) GM-CSF D) Rose bengal E) bacille Calmette-Guerin (BCG) To find out the correct answer and …